Influence of oral antidiabetic treatment on electrocardiac alterations induced by myocardial infarction

Diabetes Research and Clinical Practice

Volumn 31, Issue SUPPL., 1996, Pages

  Lomuscio, Alberto ^a   Florentini, Cesare ^a  

^a SAN PAOLO HOSPITAL   (Italy)

Author keywords

Hypoglycemic effect; Myocardial infarction; Sulfonylureas

Indexed keywords

ANTIARRHYTHMIC AGENT; CROMAKALIM; DIAZOXIDE; GLIBENCLAMIDE; ORAL ANTIDIABETIC AGENT; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; CAUSE OF DEATH; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART MUSCLE POTENTIAL; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HUMAN; INSULIN RELEASE; ION CONDUCTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION;

EID: 0029782032     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8227(96)01226-0     Document Type: Conference Paper

References (15)

1. Panten, U., Schwanstecher, M. and Schwanstecher, C. (1992) Pancreatic and extrapancreatic sulfonylurea receptor. Horm. Metab. Res. 24(12), 549-554.
2. Lynch, J.J. Jr, Sanguinetti, M.C., Kimura, S. and Bassett, A.L. (1992) Therapeutic potential of modulating potassium currents in the diseased myocardium. FASEB J 6(11), 2952-2960.
3. Lomuscio, A., Castagnone, M., Vergani, D., Verzoni, A., Beltrami, A. and Ravaglia, R. (1991) Clinical correlation between diabetic and non-diabetic patients with myocardial infarction. Acta. Cardiol. 46, 543-554.
4. Lomuscio, A., Bestetti, A., Vergani, D., Chiaramello, D., Chiti, A. and Pozzoni, L. (1992) Radionuclide assessment of left ventricular function in patients with myocardial infarction and diabetes mellitus. J. Intern. Med. 231, 73-77.
5. Kantor, P.F., Coetzee, W.A., Carmeliet, E.E., Dennis, S.C. and Opie, L.H. (1990) Reduction of ischemic potassium loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Circ. Res. 66, 478-485.
6. Fosset, M., De Weille, J.R., Green, R.D., Schmid-Antonmarchi, H. and Lazdunski, M. (1988) Antidiabetic sulfonylureas control action potential duration in heart cells via high-affinity receptors that are linked to ATP-dependent potassium channels. J. Biol. Chem. 263, 7933-7936.
7. MacKenzie, I., Waterfall, J.F., Jones, P.S. and Dunsdon, R.M. (1990) Comparison of class III antiarrhythmics and glibenclamide on action potentials from guinea pig papillary muscle under normoxic and hypoxic conditions. Br. J. Pharmacol. 100(Suppl.), p. 320.
8. Hicks, M.N. and Cobbe, S.M. (1991) Effect of glibenclamide on extracellular potassium accumulation and the electrophysiological changes during myocardial ischemia in the arterially perfused interventricular septum of rabbit. Cardiovasc. Res. 25, 407-413.
9. Cacciapuoti, F., Gentile, S., Verza, M., Spiezia, R., D'Avino, M. and Varricchio, M. (1988) Antiarrhythmic efficacy of glibenclamide on the ischemic arrhythmias in type 2 diabetic patients. Diabetologia 31, 476A.
10. Caciapuoti, F., Spiezia, R., Bianchi, U., Lamda, D., D'Avino, M. and Varricchio, M. (1991) Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus. Am. J. Cardiol. 67, 843-847.
11. Kantor, P.F., Coetzee, W.A., Dennis, S.C. and Opie, L.H. (1987) Effects of glibenclamide on ischemic arrhythmias. Circulation 65(Suppl.IV), IV 17.
12. Billman, G.E., Avendano, C.E., Halliwill, J.R. and Buroughs, J.M. (1991) Effect of the potassium channel antagonist, gibenclamide, on sudden death: protection from ventricular fibrillation. JACC 17, 165A.
13. Schmid-Antonmarchi, H., De Weille, J., Fosset, M. and Lazdunski, M. (1987) The antidiabetic sulfonylurea glibenclamide is a potent blocker of the ATP-modulated K-channel in insulin-secreting cells. Biochem. Biophys. Res. Commun. 146, 21-25.
14. Sturgess, N.C., Cook, D.L., Ashford, M.L.J. and Hales, C.N. (1985) The sulfonylurea receptor may be an ATP-sensitive potassium channel. Lancet 2, 474-475.
15. Wolleben, C.D., Sanguinetti, M.C. and Siegel, P.K.S. (1989) Influence of ATP sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. J. Mol. Cell. Cardiol. 21, 783-788.